BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

847 related articles for article (PubMed ID: 24770367)

  • 1. [Herpes Zoster and its prevention in Italy. Scientific consensus statement].
    Franco E; Gabutti G; Bonanni P; Conversano M; Stefano Valente ME; Ferro A; Icardi G; Antonio Volpi ML; Maggi S; Rossi A; Scotti S; Vitale F; Greco D;
    Ig Sanita Pubbl; 2014; 70(1):111-27. PubMed ID: 24770367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination: a new option to reduce the burden of herpes zoster.
    Mick G
    Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Pellissier JM; Brisson M; Levin MJ
    Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing the burden of Herpes Zoster in Italy.
    Gabutti G; Franco E; Bonanni P; Conversano M; Ferro A; Lazzari M; Maggi S; Rossi A; Scotti S; Vitale F; Volpi A; Greco D
    Hum Vaccin Immunother; 2015; 11(1):101-7. PubMed ID: 25483522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Herpes zoster and postherpetic neuralgia - prevention by vaccination?].
    Wutzler P
    Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S90-4. PubMed ID: 19353479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of efficacy and effectiveness of live attenuated zoster vaccine.
    Gabutti G; Valente N; Sulcaj N; Stefanati A
    J Prev Med Hyg; 2014 Dec; 55(4):130-6. PubMed ID: 26137786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity.
    Liesegang TJ
    Ophthalmology; 2008 Feb; 115(2 Suppl):S3-12. PubMed ID: 18243930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of herpes zoster and post-herpetic neuralgia in Italy: Results from a 3-years population-based study.
    Alicino C; Trucchi C; Paganino C; Barberis I; Boccalini S; Martinelli D; Pellizzari B; Bechini A; Orsi A; Bonanni P; Prato R; Iannazzo S; Icardi G
    Hum Vaccin Immunother; 2017 Feb; 13(2):399-404. PubMed ID: 27925843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes zoster vaccine: a protection for the elderly.
    Di Pietro A; FacciolĂ  A; Visalli G
    Ann Ig; 2018; 30(4 Supple 1):23-27. PubMed ID: 30062376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes zoster and postherpetic neuralgia.
    Johnson RW
    Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):21-6. PubMed ID: 20192714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.
    Marin M; Yawn BP; Hales CM; Wollan PC; Bialek SR; Zhang J; Kurland MJ; Harpaz R
    Hum Vaccin Immunother; 2015; 11(5):1157-64. PubMed ID: 25806911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands.
    de Boer PT; Pouwels KB; Cox JM; Hak E; Wilschut JC; Postma MJ
    Vaccine; 2013 Feb; 31(9):1276-83. PubMed ID: 23306360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population based study of the epidemiology of Herpes Zoster and its complications.
    Weitzman D; Shavit O; Stein M; Cohen R; Chodick G; Shalev V
    J Infect; 2013 Nov; 67(5):463-9. PubMed ID: 23872209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination against Herpes Zoster and Postherpetic Neuralgia.
    Oxman MN; Levin MJ;
    J Infect Dis; 2008 Mar; 197 Suppl 2(Suppl 2):S228-36. PubMed ID: 18419402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of herpes zoster and its painful and debilitating complications.
    Johnson R; McElhaney J; Pedalino B; Levin M
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S43-8. PubMed ID: 18162246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
    Holcomb K; Weinberg JM
    J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective cohort study evaluating the incidence of herpes zoster and postherpetic neuralgia after a live attenuated Oka-strain herpes zoster vaccine in a real-world setting in Japan.
    Yaegashi M; Matsui H; Yoshida A; Ban H; Miyazaki R; Oda N; Hattori K; Motomura Y; Usami H; Matsushita H
    Vaccine; 2024 Jan; 42(3):464-470. PubMed ID: 38172019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of herpes zoster by vaccination].
    Kofoed K; Rønholt F; Gerstoft J; Sand C
    Ugeskr Laeger; 2011 Jan; 173(2):110-4. PubMed ID: 21219841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of varicella zoster virus: chronic pain.
    Opstelten W; McElhaney J; Weinberger B; Oaklander AL; Johnson RW
    J Clin Virol; 2010 May; 48 Suppl 1():S8-13. PubMed ID: 20510265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes Zoster and Postherpetic Neuralgia: a review of the effects of vaccination.
    Johnson RW
    Aging Clin Exp Res; 2009 Jun; 21(3):236-43. PubMed ID: 19571648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.